These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23379599)

  • 41. Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines.
    Moy R; Maas C; Monheit G; Huber MB;
    Arch Facial Plast Surg; 2009; 11(2):77-83. PubMed ID: 19289677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
    Hantash BM; Gladstone HB
    Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines.
    Guerrissi J; Sarkissian P
    Ann Plast Surg; 1997 Nov; 39(5):447-53. PubMed ID: 9374139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin: clinical techniques, applications, and complications.
    Stephan S; Wang TD
    Facial Plast Surg; 2011 Dec; 27(6):529-39. PubMed ID: 22205526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commentary: The effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.
    Ahn KY
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2167. PubMed ID: 21244566
    [No Abstract]   [Full Text] [Related]  

  • 46. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L; Jun T; Bo P; Bosheng Z; Qian Z; Dongping L
    J Plast Reconstr Aesthet Surg; 2010 Dec; 63(12):2026-31. PubMed ID: 20116356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum A exotoxin for rejuvenation of the upper third of the face.
    Carucci JA; Zweibel SM
    Facial Plast Surg; 2001 Feb; 17(1):11-20. PubMed ID: 11518973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A; Carruthers J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OnabotulinumtoxinA treatment of mild glabellar lines in repose.
    Carruthers A; Carruthers J; Lei X; Pogoda JM; Eadie N; Brin MF
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2168-71. PubMed ID: 21134048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasonographic and Three-Dimensional Analyses at the Glabella and Radix of the Nose for Botulinum Neurotoxin Injection Procedures into the Procerus Muscle.
    Cho Y; Lee HJ; Lee KW; Lee KL; Kang JS; Kim HJ
    Toxins (Basel); 2019 Sep; 11(10):. PubMed ID: 31554222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Botulinum Toxin Muscle Effect in Humans Using Magnetic Resonance Imaging: A Qualitative Case Series.
    O'Dell MW; Villanueva M; Creelman C; Telhan G; Nestor J; Hentel KD; Ballon D; Dyke JP
    PM R; 2017 Dec; 9(12):1225-1235. PubMed ID: 28483684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Facing depression with botulinum toxin: a randomized controlled trial.
    Wollmer MA; de Boer C; Kalak N; Beck J; Götz T; Schmidt T; Hodzic M; Bayer U; Kollmann T; Kollewe K; Sönmez D; Duntsch K; Haug MD; Schedlowski M; Hatzinger M; Dressler D; Brand S; Holsboer-Trachsler E; Kruger TH
    J Psychiatr Res; 2012 May; 46(5):574-81. PubMed ID: 22364892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.
    Hexsel D; Hexsel C; Siega C; Schilling-Souza J; Rotta FT; Rodrigues TC
    JAMA Dermatol; 2013 Dec; 149(12):1386-91. PubMed ID: 24108521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers.
    Schroeder AS; Ertl-Wagner B; Britsch S; Schröder JM; Nikolin S; Weis J; Müller-Felber W; Koerte I; Stehr M; Berweck S; Borggraefe I; Heinen F
    Mov Disord; 2009 Jul; 24(10):1494-503. PubMed ID: 19489066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin. The Newport Beach experience.
    Fulton JE
    Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides.
    Kiripolsky MG; Peterson JD; Guiha I; Goldman MP
    Dermatol Surg; 2011 Oct; 37(10):1443-7. PubMed ID: 21649790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
    Smuts JA; Schultz D; Barnard A
    Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.